Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 2
1989 2
1991 3
1992 2
1996 1
1997 2
1998 1
2000 2
2002 1
2004 1
2005 1
2006 1
2007 2
2008 4
2010 3
2011 3
2012 2
2015 1
2016 4
2017 2
2018 1
2019 1
2020 1
2021 1
2022 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Results by year

Filters applied: . Clear all
Page 1
Pitavastatin to Prevent Cardiovascular Disease in HIV Infection.
Grinspoon SK, Fitch KV, Zanni MV, Fichtenbaum CJ, Umbleja T, Aberg JA, Overton ET, Malvestutto CD, Bloomfield GS, Currier JS, Martinez E, Roa JC, Diggs MR, Fulda ES, Paradis K, Wiviott SD, Foldyna B, Looby SE, Desvigne-Nickens P, Alston-Smith B, Leon-Cruz J, McCallum S, Hoffmann U, Lu MT, Ribaudo HJ, Douglas PS; REPRIEVE Investigators. Grinspoon SK, et al. N Engl J Med. 2023 Aug 24;389(8):687-699. doi: 10.1056/NEJMoa2304146. Epub 2023 Jul 23. N Engl J Med. 2023. PMID: 37486775 Free PMC article. Clinical Trial.
Review of tenofovir-emtricitabine.
Masho SW, Wang CL, Nixon DE. Masho SW, et al. Among authors: nixon de. Ther Clin Risk Manag. 2007 Dec;3(6):1097-104. Ther Clin Risk Manag. 2007. PMID: 18516268 Free PMC article.
Biomarkers of immune dysfunction in HIV.
Nixon DE, Landay AL. Nixon DE, et al. Curr Opin HIV AIDS. 2010 Nov;5(6):498-503. doi: 10.1097/COH.0b013e32833ed6f4. Curr Opin HIV AIDS. 2010. PMID: 20978393 Free PMC article. Review.
Cytomegalovirus viremia and risk of disease progression and death in HIV-positive patients starting antiretroviral therapy.
Levi LI, Sharma S, Schleiss MR, Furrer H, Nixon DE, Blackstad M, Hernandez-Alvarado N, Dwyer DE, Borges AH, Lane HC, Lundgren J, Neaton JD, Molina JM; INSIGHT ANRS study groups. Levi LI, et al. Among authors: nixon de. AIDS. 2022 Jul 15;36(9):1265-1272. doi: 10.1097/QAD.0000000000003238. Epub 2022 Apr 19. AIDS. 2022. PMID: 35442221 Free PMC article.
When to start antiretroviral therapy.
Wang C, Masho SW, Nixon DE. Wang C, et al. Among authors: nixon de. Curr HIV/AIDS Rep. 2006 Jul;3(2):66-73. doi: 10.1007/s11904-006-0020-3. Curr HIV/AIDS Rep. 2006. PMID: 16608662 Review.
Associations between baseline biomarkers and lung function in HIV-positive individuals.
MacDonald DM, Zanotto AD, Collins G, Baker JV, Czarnecki M, Loiza E, Nixon DE, Papastamopoulos V, Wendt CH, Wood R, Kunisaki KM; INSIGHT START Pulmonary Substudy Group. MacDonald DM, et al. Among authors: nixon de. AIDS. 2019 Mar 15;33(4):655-664. doi: 10.1097/QAD.0000000000002101. AIDS. 2019. PMID: 30601153 Free PMC article.
Patterns of Antiretroviral Therapy Use and Immunologic Profiles at Enrollment in the REPRIEVE Trial.
Fichtenbaum CJ, Ribaudo HJ, Leon-Cruz J, Overton ET, Zanni MV, Malvestutto CD, Aberg JA, Kileel EM, Fitch KV, Van Schalkwyk M, Kumarasamy N, Martinez E, Santos BR, Joseph Y, Lo J, Siminski S, Melbourne K, Sponseller CA, Desvigne-Nickens P, Bloomfield GS, Currier JS, Hoffmann U, Douglas PS, Grinspoon SK; REPRIEVE Investigators. Fichtenbaum CJ, et al. J Infect Dis. 2020 Jul 9;222(Suppl 1):S8-S19. doi: 10.1093/infdis/jiaa259. J Infect Dis. 2020. PMID: 32645162 Free PMC article.
45 results